Skip to main content
. 2021 Jul 20;13:17588359211029826. doi: 10.1177/17588359211029826

Figure 1.

Figure 1.

Programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) immune checkpoint inhibitors (ICIs) approved for the treatment of lung cancer in China and their respective approved indications.